METABOLOMICS, GENOMICS AND LIPIDOMICS REVEAL NOVEL SIGNATURES OF HYDROCHLOROTHIAZIDE RESPONSE IN PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES (PEAR) STUDY.

Shahin M. H.; Gong Y.; Langaee T.; Beitel-Shees A. L.; Rotroff D. M.; Chapman A. B.; Gums J. G.; Turner S. T.; Motsinger-Reif A.; Frye R. F.; Fiehn O.; Johnson J. A.; Cooper-DeHoff R.; Han X.; Kaddurah-Daouk R.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >METABOLOMICS, GENOMICS AND LIPIDOMICS REVEAL NOVEL SIGNATURES OF HYDROCHLOROTHIAZIDE RESPONSE IN PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES (PEAR) STUDY.

【24h】

METABOLOMICS, GENOMICS AND LIPIDOMICS REVEAL NOVEL SIGNATURES OF HYDROCHLOROTHIAZIDE RESPONSE IN PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES (PEAR) STUDY.

机译：药物遗传学评价抗高血压反应（梨）研究中氢氯噻嗪的代谢组学，基因组学和脂质学研究揭示了新的特征。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2015年第s1期|共1页
作者
Shahin M. H.; Gong Y.; Langaee T.; Beitel-Shees A. L.; Rotroff D. M.; Chapman A. B.; Gums J. G.; Turner S. T.; Motsinger-Reif A.; Frye R. F.; Fiehn O.; Johnson J. A.; Cooper-DeHoff R.; Han X.; Kaddurah-Daouk R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. METABOLOMICS, GENOMICS AND LIPIDOMICS REVEAL NOVEL SIGNATURES OF HYDROCHLOROTHIAZIDE RESPONSE IN PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES (PEAR) STUDY. [J] . Shahin M. H., Gong Y., Langaee T., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：药物遗传学评价抗高血压反应（梨）研究中氢氯噻嗪的代谢组学，基因组学和脂质学研究揭示了新的特征。
2. INTEGRATING METABOLOMICS AND GENOMICS REVEALS NOVEL BIOMARKERS OF HYDROCHLOROTHIAZIDE RESPONSE IN PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES (PEAR) STUDY. [J] . Shahin M. H., Rotroff D. M., Gong Y., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：代谢组学和基因组学的集成揭示了盐酸氟噻嗪反应的新生物标志物在抗高血压反应（梨）药物遗传学评估中的作用。
3. INTEGRATING METABOLOMICS AND GENOMICS REVEALS NOVEL BIOMARKERS OF HYDROCHLOROTHIAZIDE RESPONSE IN PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES (PEAR) STUDY. [J] . Shahin M. H., Rotroff D. M., Gong Y., Clinical Pharmacology and Therapeutics . 2015,第S1期

机译：代谢组学和基因组学的集成揭示了盐酸氟噻嗪反应的新生物标志物在抗高血压反应（梨）药物遗传学评估中的作用。
4. (cest2017_01059) Liquid Chromatography-Mass Spectrometry-based Metabolomics and Lipidomics Reveal Toxicological Mechanisms of Bisphenol F in Breast Cancer Xenografts [C] . Zhao C., X?e P, Song Y. International Conference on Environmental Science and Technology . 2017

机译：（CEST2017_01059）液相色谱 - 质谱基代代谢组和脂质虫揭示乳腺癌异种移植物中双酚F的毒理学机制
5. Metformin Pharmacogenomics: Functional Genomics of CDC25b and TPD54 Regulation of Metformin Anticancer Response in Breast Cancer [D] . Ly, Reynold. 2018

机译：二甲双胍药物基因组学：CDC25b和TPD54的功能基因组学对乳腺癌二甲双胍抗癌反应的调控
6. Hydrochlorothiazide-induced hyperuricaemia in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study [O] . Alexander G. Vandell, Caitrin W. McDonough, Yan Gong, -1

机译：氢氯噻嗪诱导的高尿酸血症在抗高血压反应的药物基因组学评估中的应用
7. Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study. [O] . Caitrin W McDonough, Nancy K Gillis, Abdullah Alsultan, 2013

机译：阿替洛尔在抗高血压反应（pEaR）研究的药物基因组学评估中诱导HDL-C变化。

METABOLOMICS, GENOMICS AND LIPIDOMICS REVEAL NOVEL SIGNATURES OF HYDROCHLOROTHIAZIDE RESPONSE IN PHARMACOGENOMIC EVALUATION OF ANTIHYPERTENSIVE RESPONSES (PEAR) STUDY.

著录项

相似文献

相关主题

期刊订阅